BMI1 and neoplasm: Tumor-associated epithelial ATII-like clusters and the epithelial cluster specific to mutant-KRAS ADCs, are positive for the oncogene BMI-1, and, according to our hypothesis, responsive to PTC596 in vivo treatment.